SE-Therapeutics Email Formats

Biotechnology Research • Corbeil-Essonnes, Île-de-France, France • 1-10 Employees

Key Contact at SE-Therapeutics

Erwan Bezard

Co-Founder, Scientific Board Member & Shareholder

Company overview

Headquarters	4 rue Pierre Fontaine, Evry, 91058, FR
Phone number	+33623780239
Websites	se-thx.com setherapeutics.com
NAICS	541714
Keywords	Biotechnology, Nanobodies, Protein Production, Crispr Cas
Founded	2022
Employees	1-10

About SE-Therapeutics

SE-Therapeutics stands for Self-Entering Therapeutics. We are a company that has conceived an innovative technology for the intracellular delivery of single chain antibodies, and gene editing RNPs. Our mission is to provide life changing cures to patients suffering from incurable diseases such as cancer and neurodegenerative disorders.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Founder/Owner

Employees by Department

SE-Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

SE-Therapeutics has never raised funding before.

SE-Therapeutics Tech Stack

Discover the technologies and tools that power SE-Therapeutics's digital infrastructure, from frameworks to analytics platforms.

WPForms

Form builders

Google Maps

Maps

jQuery Migrate

JavaScript libraries

Blocksy

WordPress themes

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

PHP

Programming languages

WordPress

Blogs

Gutenberg

Editors

Yoast SEO

SEO

Blocksy Companion

WordPress plugins

Frequently asked questions

SE-Therapeutics is located in Corbeil-Essonnes, Île-de-France, FR.

You can reach SE-Therapeutics at +33623780239.

SE-Therapeutics was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

SE-Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at SE-Therapeutics

Erwan Bezard

Co-Founder, Scientific Board Member & Shareholder

4.8

40,000 users